Re-appointment of Dr. Pooja Jain (DIN: 00097037) as Whole Time Director for a term of 5 years and Appointment of Secretarial Auditor M/s Kuldeep Dahiya & Associates for a period of 5 years.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At the 38th AGM held on September 25, 2025, shareholders approved three key items. First, the authorized share capital was doubled from Rs. 15.5 crore to Rs. 30 crore by creating an additional 1.45 crore equity shares of Rs. 10 each, suggesting room for future fundraising, bonus issue, or stock split. Second, Dr. Pooja Jain (DIN: 00097037) was re-appointed as Whole Time Director for another 5-year term (October 14, 2025 to October 13, 2030); she has been on the board since October 14, 2015 and holds a Doctorate from University of Maryland, USA, with 9+ years of experience. Third, M/s Kuldeep Dahiya & Associates, Company Secretaries, was appointed as Secretarial Auditor for 5 years from FY 2025-26 to FY 2029-30. The disclosure also reveals promoter family involvement on the board — Dr. Pooja Jain's spouse Sanjay Jain is a Director and her son Piyush Jain is the CEO.
The authorized capital increase gives the company flexibility to raise fresh funds or reward shareholders through a bonus issue, which could dilute existing holdings if new shares are issued. The re-appointment of the existing WTD ensures leadership continuity, while the appointment of a new secretarial auditor for a 5-year term is a routine compliance matter. No negative governance flags were reported.